Medicine and Dentistry
Prostate Cancer
100%
In Vitro
80%
Androgen
80%
Programmed Cell Death
40%
Cell Cycle
40%
Docetaxel
40%
Lysine
40%
Transcription Factors
20%
Cell Proliferation
20%
Androgen Receptor
20%
Cancer Cell
20%
Metastatic Carcinoma
20%
Overall Survival
20%
Prostate Cancer Cell Line
20%
Cell Line
20%
Binding Site
20%
Histone H3
20%
Localized Disease
20%
Androgen Deprivation Therapy
20%
Chromatin Immunoprecipitation
20%
Prostate Adenocarcinoma
20%
Histone Demethylase
20%
LNCaP Cell Line
20%
Cabazitaxel
20%
Messenger RNA
20%
Neuroscience
Androgen
100%
Prostate
100%
In Vitro
80%
Cell Line
60%
Cell Cycle
40%
Lysine
40%
Docetaxel
40%
Taxane
40%
Programmed Cell Death
40%
Transcription Factors
20%
Cell Proliferation
20%
Binding Site
20%
Histone H3
20%
Immunoprecipitation
20%
Demethylase
20%
Histone Demethylase
20%
Androgen Receptor
20%
Cabazitaxel
20%
Messenger RNA
20%
Biochemistry, Genetics and Molecular Biology
LNCaP
100%
Cancer Cell
66%
Cell Cycle
66%
Demethylase
66%
Lysine
66%
Programmed Cell Death
66%
Cell Proliferation
33%
Binding Site
33%
Androgen Receptor
33%
Transcription Factors
33%
Overall Survival
33%
Histone H3
33%
Chromatin Immunoprecipitation
33%
Messenger RNA
33%
Histone
33%
Keyphrases
Hormone-sensitive Prostate Cancer
100%
MYBL2
100%
KDM5D
69%
Androgen Deprivation Therapy
40%
Clinical Outcomes
20%
LNCaP
20%
Docetaxel
20%
Taxanes
20%
Cell Cycle Distribution
20%
Apoptosis
10%
Transcription Factor
10%
Cell Proliferation
10%
Overexpression
10%
Overall Survival
10%
Prostate Carcinoma
10%
Prostate Cancer Cells
10%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
10%
Metastatic Disease
10%
MRNA Expression
10%
Prostate Cancer Cell Lines
10%
Binding Site
10%
Histone H3
10%
Localized Disease
10%
In Vitro Assay
10%
Androgen-independent
10%
Chromatin Immunoprecipitation (ChIP)
10%
Lysine
10%
Trimethylation
10%
Proliferation Apoptosis
10%
LSD1
10%
Histone Demethylase
10%
In Vitro Resistance
10%
Clinical Samples
10%
Cabazitaxel
10%
Androgen Receptor-positive
10%
LNCaP Cell Line
10%
CHAARTED
10%
In Vitro Adaptation
10%
Immunology and Microbiology
Prostate
100%
Cell Cycle
50%
Programmed Cell Death
50%
Histone
50%
Lysine
50%
Binding Site
25%
Cell Proliferation
25%
Cancer Cell
25%
Overall Survival
25%
Transcription Factors
25%
Cell Line
25%
Prostate Cancer Cell Line
25%
Chromatin Immunoprecipitation
25%
LNCaP Cell Line
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen
83%
Docetaxel
33%
Lysine
33%
Taxane
33%
Binding Site
16%
Overall Survival
16%
Androgen Receptor
16%
Metastasis
16%
Transcription Factors
16%
Prostate Adenocarcinoma
16%
Histone Demethylase
16%
Histone H3
16%
Chromatin Immunoprecipitation
16%
Cabazitaxel
16%
Messenger RNA
16%
Diseases
16%